col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


31 Ergebisse       Seite 1

 [1] 
IOS Press: International Journal of Risk & Safety in Medicine
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2023―Jun―20 Impact of the COVID-19 pandemic on dispensing medicines in the community pharmacy Shafq Al-Azzawi, Dhafir Masheta
2 [GO] 2023―Mai―05 Workplace policies and quality of working life (QoWL) during the COVID-19 pandemic in Jordanian hospitals Mohammad S. Alyahya, Salam Momani, Main Naser Alolayyan, Yousef S. Khader
3 [GO] 2023―Mai―05 Acute renal failure and cardiac arrhythmias associated with remdesivir use in patients with COVID-19 infections: Analysis using the US FDA adverse event reporting system Lisajo Orogun, Te-yuan Chyou, Prasad S. Nishtala
4 [GO] 2023―Mai―05 Healthcare-acquired Sars-Cov-2 infection: A viable legal category? Vittorio Bolcato, Livio Pietro Tronconi, Anna Odone, Lorenzo Blandi
5 [GO] 2022―Nov―22 Patient safety culture in a COVID-19 ICU compared to a clinical-surgical ICU in the Brazilian Eastern Amazon: A cross-sectional study Maria Luiza Rodrigues dos Santos, Victória Brioso Tavares, Natália Silva da Costa, Marcos Valério Santos da Silva, João Simão de Melo-Neto
6 [GO] 2022―Jul―26 Patients’ perception of personal protective equipment during the SARS-Cov-2 pandemic Aly Zaheer Pathan, Jennifer Barwell, Artemis Kastrissianakis, Kiran Awan, Anie Abila, Amelia Lim, et al. (+4)
7 [GO] 2022―Jul―22 Lessons learned from the COVID-19 pandemic: Improving initial investigations with the implementation of a COVID-19 blood request panel Lavandan Jegatheeswaran, Byung Choi, Martin Cohn, Amal Minocha, Ernest Mutengesa, Ashik Zala, et al. (+2)
8 [GO] 2022―Jul―01 Approach to the management of COVID-19 patients: When home care can represent the best practice Gerardo Tricarico, Valter Travagli
9 [GO] 2022―Apr―22 Response to “An old entity, a new trigger: Post COVID-19 vaccine pityriasis rubra pilaris” Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
10 [GO] 2022―Mrz―15 Global pandemic vaccine development, production and distribution challenges for the world population Rade Injac, Vlasta Sikimić, Mike Stuart, Jamie Shaw
11 [GO] 2022―Mrz―11 Science funding policy and the COVID-19 pandemic Vlasta Sikimić, Mike Stuart, Jamie Shaw, Vlasta Sikimić, Mike Stuart, Jamie Shaw
12 [GO] 2022―Mrz―11 The social organization of science during the COVID-19 pandemic Manuela Fernández Pinto, Vlasta Sikimić, Mike Stuart, Jamie Shaw
13 [GO] 2022―Feb―22 Predicaments during a period of health emergency: Waiving patent protections or innovative public procurement? The example of advance purchase agreements (APA) for COVID-19 vaccines Nuria Garrido Cuenca, Carlo Bottari
14 [GO] 2022―Feb―11 Obesity and immune system impairment: A global problem during the COVID-19 pandemic Rosa Manca, Francisco Bombillar, Chester Glomski, Alessandra Pica, Carlo Bottari
15 [GO] 2022―Feb―11 EU health co-design policies to counteract the covid-19 pandemic effect promoting physical activity Luca Zambelli, Francesco Pegreffi, Carlo Bottari
16 [GO] 2021―Okt―29 Social distance capacity to control the COVID-19 pandemic: A systematic review on time series analysis Omid Khosravizadeh, Bahman Ahadinezhad, Aisa Maleki, Zahra Najafpour, Rohollah Golmohammadi
17 [GO] 2021―Aug―20 An old entity, a new trigger: Post COVID-19 vaccine Pityriasis rubra pilaris Mukesh Kumar Sahni, Kanika Roy, Dinesh Prasad Asati, Ujjawal Khurana
18 [GO] 2021―Feb―12 Healthcare risk management during the SARS-CoV-2 virus pandemic in the European Union: The guaranteed access to medicines Silvia Enríquez-Fernández, Carlos del Castillo-Rodríguez
19 [GO] 2020―Dez―29 Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective Kavita Manchanda, Jasbir Singh, Ranjeev Bhagat, Ilmjot Kaur Tiwana, Harmanjit Singh
20 [GO] 2020―Nov―06 The issues of individualized medicine and pharmacovigilance: A consideration of COVID-19 and vaccination I. Ralph Edwards, Marie Lindquist
21 [GO] 2020―Okt―06 Perspectives on COVID-19 Arthur Dunkley
22 [GO] 2020―Aug―25 COVID-19 and healthcare-associated infections Andrea Cioffi, Raffaella Rinaldi
23 [GO] 2020―Jul―31 Does COVID-19 teach us anything for our future? Ivor Ralph Edwards, Marie Lindquist
24 [GO] 2020―Jun―26 A risk balancing act - tourism competition using health leverage in the COVID-19 era Victor Grech, Peter Grech, Stephanie Fabri
25 [GO] 2020―Jun―19 Some reflections on organizational profiles in Italy in the time of COVID-19 Carlo Bottari
26 [GO] 2020―Mai―29 Risk of using hydroxychloroquine as a treatment of COVID-19 Lo’ai Alanagreh, Foad Alzoughool, Manar Atoum
27 [GO] 2020―Apr―17 Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19 Foad Alzoughool, Lo’ai Alanagreh
28 [GO] 2019―Dez―03 Pandemic influenza vaccines and neuraminidase inhibitors: Efficacy and side effects D. Bijl
29 [GO] 2019―Dez―03 The sponsored pandemic of the Mexican flu? D. Bijl, H. Schellekens
30 [GO] 2019―Dez―03 Does seasonal influenza vaccination increase the risk of illness with the 2009 A/H1N1 pandemic virus? Cécile Viboud, Lone Simonsen
31 [GO] 2019―Dez―03 Factors influencing uptake of influenza vaccine amongst healthcare workers in a regional center after the A(H1N1) 2009 pandemic: Lessons for improving vaccination rates Mohamed Rida Tagajdid, Hicham El Annaz, Bouchra Belefquih, Taoufik Doblali, Jean Sébastien Casalegno, Yahia Mekki, Saâd Mrani
 [1] 

31 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.007 sec